Because of the association of renal dysfunction with cardiovascular disease, it is unclear whether cystatin C is a direct marker of cardiovascular disease or merely a marker for renal failure, which has implications for therapeutic intervention. This evidence concerns the gene CST3 and Abnormal renal physiology.